U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07107035) titled 'Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer' on July 30.
Brief Summary: The goal of this nationwide, multicenter observational study is to develop and externally validate multimodal large models that can (1) predict the risk of brain metastases and (2) estimate long-term prognosis in patients with non-small cell lung cancer (NSCLC).
The main questions it aims to answer are:
* Can a multimodal large model that fuses imaging, pathology, genomic, and clinical data accurately identify NSCLC patients at high risk of developing brain metastases?
* Can a multimodal large model reliably ...